Analysts foresee record year for Allergan

Allergan will announce it's last quarter's results tomorrow. Based on the analysts' consensus: both the revenue and the net result would be the highest in years. For this year Allergan 's revenue will be around 15,8 billion USD. This is according to the average of the analysts' estimates. The expected revenue would be a record for the company. This is slightly more than 2016's revenue of 14,57 billion USD.

Historical revenues and results Allergan plus estimates 2017

The analysts anticipate for 2017 a record net profit a 5,72 billion USD. For this year the majority of the analysts, consulted by press agency Thomson Reuters, expects a profit per share of 16,08 USD. So the price/earnings-ratio equals 15,68.

For this year the analysts expect a dividend of 2,89 USD per share. Thus the dividend yield equals 1,15 percent. The average dividend yield of the pharmaceutical companies equals a low 1,33 percent.

Historical stock prices Allergan past 10 years

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.